288 related articles for article (PubMed ID: 11739273)
1. CD40 signaling and plaque instability.
Schönbeck U; Libby P
Circ Res; 2001 Dec; 89(12):1092-103. PubMed ID: 11739273
[TBL] [Abstract][Full Text] [Related]
2. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis.
Mach F; Schönbeck U; Sukhova GK; Bourcier T; Bonnefoy JY; Pober JS; Libby P
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1931-6. PubMed ID: 9050882
[TBL] [Abstract][Full Text] [Related]
3. CD40 signaling in vascular cells: a key role in atherosclerosis?
Mach F; Schönbeck U; Libby P
Atherosclerosis; 1998 Apr; 137 Suppl():S89-95. PubMed ID: 9694547
[TBL] [Abstract][Full Text] [Related]
4. Expression of stromelysin-3 in atherosclerotic lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivo.
Schönbeck U; Mach F; Sukhova GK; Atkinson E; Levesque E; Herman M; Graber P; Basset P; Libby P
J Exp Med; 1999 Mar; 189(5):843-53. PubMed ID: 10049948
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice.
Schönbeck U; Sukhova GK; Shimizu K; Mach F; Libby P
Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7458-63. PubMed ID: 10861012
[TBL] [Abstract][Full Text] [Related]
6. Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells.
Schönbeck U; Gerdes N; Varo N; Reynolds RS; Horton DB; Bavendiek U; Robbie L; Ganz P; Kinlay S; Libby P
Circulation; 2002 Dec; 106(23):2888-93. PubMed ID: 12460867
[TBL] [Abstract][Full Text] [Related]
7. Reduction of atherosclerosis in mice by inhibition of CD40 signalling.
Mach F; Schönbeck U; Sukhova GK; Atkinson E; Libby P
Nature; 1998 Jul; 394(6689):200-3. PubMed ID: 9671306
[TBL] [Abstract][Full Text] [Related]
8. Macrophages, smooth muscle cells, endothelial cells, and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions. Colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor, and CD16 (Fc gammaRIII).
Häkkinen T; Karkola K; Ylä-Herttuala S
Virchows Arch; 2000 Oct; 437(4):396-405. PubMed ID: 11097365
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD40 in vascular smooth muscle cells and macrophages is associated with early development of human atherosclerotic lesions.
Bruemmer D; Riggers U; Holzmeister J; Grill M; Lippek F; Settmacher U; Regitz-Zagrosek V; Fleck E; Graf K
Am J Cardiol; 2001 Jan; 87(1):21-7. PubMed ID: 11137828
[TBL] [Abstract][Full Text] [Related]
10. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture?
Schönbeck U; Mach F; Sukhova GK; Murphy C; Bonnefoy JY; Fabunmi RP; Libby P
Circ Res; 1997 Sep; 81(3):448-54. PubMed ID: 9285647
[TBL] [Abstract][Full Text] [Related]
11. CD40 ligand is selectively expressed on CD4+ T cells and platelets: implications for CD40-CD40L signalling in atherosclerosis.
Büchner K; Henn V; Gräfe M; de Boer OJ; Becker AE; Kroczek RA
J Pathol; 2003 Oct; 201(2):288-95. PubMed ID: 14517846
[TBL] [Abstract][Full Text] [Related]
12. CD40 ligation induces tissue factor expression in human vascular smooth muscle cells.
Schönbeck U; Mach F; Sukhova GK; Herman M; Graber P; Kehry MR; Libby P
Am J Pathol; 2000 Jan; 156(1):7-14. PubMed ID: 10623647
[TBL] [Abstract][Full Text] [Related]
13. Atherosclerosis as an inflammatory disease.
Tuttolomondo A; Di Raimondo D; Pecoraro R; Arnao V; Pinto A; Licata G
Curr Pharm Des; 2012; 18(28):4266-88. PubMed ID: 22390643
[TBL] [Abstract][Full Text] [Related]
14. The CD40/CD154 receptor/ligand dyad.
Schönbeck U; Libby P
Cell Mol Life Sci; 2001 Jan; 58(1):4-43. PubMed ID: 11229815
[TBL] [Abstract][Full Text] [Related]
15. Co-stimulators CD40-CD40L, a potential immune-therapy target for atherosclerosis: A review.
Tian S; Wang Y; Wan J; Yang M; Fu Z
Medicine (Baltimore); 2024 Apr; 103(14):e37718. PubMed ID: 38579073
[TBL] [Abstract][Full Text] [Related]
16. CD40 and vascular inflammation.
Urbich C; Dimmeler S
Can J Cardiol; 2004 May; 20(7):681-3. PubMed ID: 15197419
[TBL] [Abstract][Full Text] [Related]
17. Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile.
Lutgens E; Lievens D; Beckers L; Wijnands E; Soehnlein O; Zernecke A; Seijkens T; Engel D; Cleutjens J; Keller AM; Naik SH; Boon L; Oufella HA; Mallat Z; Ahonen CL; Noelle RJ; de Winther MP; Daemen MJ; Biessen EA; Weber C
J Exp Med; 2010 Feb; 207(2):391-404. PubMed ID: 20100871
[TBL] [Abstract][Full Text] [Related]
18. Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice.
Inoue S; Egashira K; Ni W; Kitamoto S; Usui M; Otani K; Ishibashi M; Hiasa K; Nishida K; Takeshita A
Circulation; 2002 Nov; 106(21):2700-6. PubMed ID: 12438296
[TBL] [Abstract][Full Text] [Related]
19. Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease.
Lacy M; Bürger C; Shami A; Ahmadsei M; Winkels H; Nitz K; van Tiel CM; Seijkens TTP; Kusters PJH; Karshovka E; Prange KHM; Wu Y; Brouns SLN; Unterlugauer S; Kuijpers MJE; Reiche ME; Steffens S; Edsfeldt A; Megens RTA; Heemskerk JWM; Goncalves I; Weber C; Gerdes N; Atzler D; Lutgens E
Nat Commun; 2021 Jun; 12(1):3754. PubMed ID: 34145241
[TBL] [Abstract][Full Text] [Related]
20. Proangiogenic function of CD40 ligand-CD40 interactions.
Reinders ME; Sho M; Robertson SW; Geehan CS; Briscoe DM
J Immunol; 2003 Aug; 171(3):1534-41. PubMed ID: 12874247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
